- Methadone Replacement Therapy (MRT) is one of the "Harm Reduction"
program established for opioid abusers. - The aim of this program is mainly to o prevent blood-borne viral infections (HIV, Hepatitis C, Hepatitis B) due to needles sharing. o Improve quality of life o Reduce craving and withdrawal symptoms. - Synthetic Opioid Agonist.
Pharmacology time of onset: 30 min
peak effects: 3 hours Half life : 24 hours Time to reach stabilization: 3 to 10 days Side effects - Drowsiness - Nausea and vomiting - Difficulty in urination - Mood changes - Sleep problems - Decrease in sexual desire and ability Contraindications - Primary addiction not opioid based - Severe hepatic impairment - Hypersensitivity to methadone - Severe respiratory depression - Head injury - Raised ICP - Acute Alcoholism - Receiving MAOI or within 14 days of stopping such treatment - Addiction less than 1 year Criteria for MRT - Above 18 years old - Voluntary - Primary addiction opiate based drugs - Adhere to rules and regulation Termination of - Aggression, causing damage to property and physical MRT well being of staffs - Misuse of take away dosage - Distributing drugs at treatment facility - Verbal threats Investigations - Infective status -TB/HIV/HEP B Hep C prior to initiation - LFT - Urine for drugs - ECG - for those taking 100mg and above. (QTc) Treatment Induction Titration Maintenance dosing phases • starting dose 20- • 1st two weeks is • may require higher 30mg mainly aimed at doses during • followed by achieving maintenance than monitoring for 3-4hrs stabilization induction phase for signs of according to patient's • usually ranges toxicity/withdrawal. needs between 60-80mg • If develops • 5-10mg increment • take into withdrawal within every 3 days consideration the 4hrs, consider taking • not more than 20mg following: 5mg total increase per opatient's metabolism • may consider week opregnancy starting at doses • end dose in 1st week opolysubstance higher than 30mg is not to exceed oother medications: but no more than 50mg antiTB/ Antiretroviral/ 40mg • advise patient not to psychotropics • monitor for 3-4hr for handle machinery or the first 3 days drive during titration phase
Patient - Should be done actively during first 2 weeks of induction
Surveillance - Ideally daily by MO - At least 2 x in a week - Considerations o Withdrawal o Intoxication o Other drug use o Adherence to rules o Patient’s perception to dosage adequacy. Dose reduction - 10mg reduction per week till dosage is 40mg - Then 5mg reduction per week -